Clinical validation of an abbreviated karyotype analysis protocol for fertility evaluation
Pathology · 2024
DOI: 10.1016/j.pathol.2024.04.010 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Pathology, 2024. Verfasst von Eric Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cytogenetics Department, Virtus Diagnostics, Milton, Qld, Australia; Molecular Genetics Department, Virtus Diagnostics, Revesby, NSW, Australia. Elec…. Hauptthemen laut MEDLINE: Karyotyping, Mosaicism. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cytogenetics Department, Virtus Diagnostics, Milton, Qld, Australia; Molecular Genetics Department, Virtus Diagnostics, Revesby, NSW, Australia. Electronic address: dr.ericlee@outlook.com.
- Molecular Genetics Department, Virtus Diagnostics, Revesby, NSW, Australia.
- Cytogenetics Department, Virtus Diagnostics, Milton, Qld, Australia.
Zitieren
APA
Lee, E., Orton, K., Langton, M., Irving, J., & Evans, K. (2024). Clinical validation of an abbreviated karyotype analysis protocol for fertility evaluation. Pathology. https://doi.org/10.1016/j.pathol.2024.04.010
Vancouver
Lee E, Orton K, Langton M, Irving J, Evans K. Clinical validation of an abbreviated karyotype analysis protocol for fertility evaluation. Pathology. 2024. doi:10.1016/j.pathol.2024.04.010
BibTeX
@article{Lee2024,
author = {Lee, Eric and Orton, Kaylee and Langton, Meg and Irving, Jodi and Evans, Ken},
title = {Clinical validation of an abbreviated karyotype analysis protocol for fertility evaluation},
journal = {Pathology},
year = {2024},
doi = {10.1016/j.pathol.2024.04.010}
}
EUVIMED